Pectoralis muscle area as a predictor of mortality in patients hospitalized with bronchiectasis exacerbation
S. Karger AG, Basel..
INTRODUCTION: Data on factors related to mortality in patients with bronchiectasis exacerbation are insufficient. Computerized tomography (CT) can measure the pectoralis muscle area (PMA) and is a useful tool to diagnose sarcopenia. This study aimed to evaluate whether PMA can predict mortality in patients with bronchiectasis exacerbation.
METHODS: Patients hospitalized due to bronchiectasis exacerbation at a single center were retrospectively divided into survivors and non-survivors based on 1-year mortality. Thereafter, a comparison of the clinical and radiologic characteristics was conducted between the two groups.
RESULTS: A total of 66 (14%) patients died at 1 year. In the multivariate analysis, age, body mass index (BMI) < 18.4 kg/m2, sex-specific PMA quartile, ≥ 3 exacerbations in the previous year, serum albumin < 3.5 g/dL, cystic bronchiectasis, tuberculosis-destroyed lung, and diabetes mellitus were independent predictors for the 1-year mortality in patients hospitalized with bronchiectasis exacerbation. A lower PMA was associated with a lower overall survival rate in the survival analysis according to sex-specific quartiles of PMA. PMA had the highest area under the curve during assessment of prognostic performance in predicting the 1-year mortality. The lowest sex-specific PMA quartile group exhibited higher disease severity than the highest quartile group.
CONCLUSIONS: CT-derived PMA was an independent predictor of 1-year mortality in patients hospitalized with bronchiectasis exacerbation. Patients with lower PMA exhibited higher disease severity. These findings suggest that PMA might be a useful marker for providing additional information regarding prognosis of patients with bronchiectasis exacerbation.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
Respiration; international review of thoracic diseases - (2024) vom: 18. März |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Seo, Hyewon [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 18.03.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1159/000538091 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369886461 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM369886461 | ||
003 | DE-627 | ||
005 | 20240319233446.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240319s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1159/000538091 |2 doi | |
028 | 5 | 2 | |a pubmed24n1336.xml |
035 | |a (DE-627)NLM369886461 | ||
035 | |a (NLM)38499001 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Seo, Hyewon |e verfasserin |4 aut | |
245 | 1 | 0 | |a Pectoralis muscle area as a predictor of mortality in patients hospitalized with bronchiectasis exacerbation |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 18.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a S. Karger AG, Basel. | ||
520 | |a INTRODUCTION: Data on factors related to mortality in patients with bronchiectasis exacerbation are insufficient. Computerized tomography (CT) can measure the pectoralis muscle area (PMA) and is a useful tool to diagnose sarcopenia. This study aimed to evaluate whether PMA can predict mortality in patients with bronchiectasis exacerbation | ||
520 | |a METHODS: Patients hospitalized due to bronchiectasis exacerbation at a single center were retrospectively divided into survivors and non-survivors based on 1-year mortality. Thereafter, a comparison of the clinical and radiologic characteristics was conducted between the two groups | ||
520 | |a RESULTS: A total of 66 (14%) patients died at 1 year. In the multivariate analysis, age, body mass index (BMI) < 18.4 kg/m2, sex-specific PMA quartile, ≥ 3 exacerbations in the previous year, serum albumin < 3.5 g/dL, cystic bronchiectasis, tuberculosis-destroyed lung, and diabetes mellitus were independent predictors for the 1-year mortality in patients hospitalized with bronchiectasis exacerbation. A lower PMA was associated with a lower overall survival rate in the survival analysis according to sex-specific quartiles of PMA. PMA had the highest area under the curve during assessment of prognostic performance in predicting the 1-year mortality. The lowest sex-specific PMA quartile group exhibited higher disease severity than the highest quartile group | ||
520 | |a CONCLUSIONS: CT-derived PMA was an independent predictor of 1-year mortality in patients hospitalized with bronchiectasis exacerbation. Patients with lower PMA exhibited higher disease severity. These findings suggest that PMA might be a useful marker for providing additional information regarding prognosis of patients with bronchiectasis exacerbation | ||
650 | 4 | |a Journal Article | |
700 | 1 | |a Cha, Seung-Ick |e verfasserin |4 aut | |
700 | 1 | |a Park, Jongmin |e verfasserin |4 aut | |
700 | 1 | |a Lim, Jae-Kwang |e verfasserin |4 aut | |
700 | 1 | |a Lee, Won Kee |e verfasserin |4 aut | |
700 | 1 | |a Park, Ji-Eun |e verfasserin |4 aut | |
700 | 1 | |a Choi, Sun Ha |e verfasserin |4 aut | |
700 | 1 | |a Lee, Yong Hoon |e verfasserin |4 aut | |
700 | 1 | |a Yoo, Seung-Soo |e verfasserin |4 aut | |
700 | 1 | |a Lee, Shin-Yup |e verfasserin |4 aut | |
700 | 1 | |a Lee, Jaehee |e verfasserin |4 aut | |
700 | 1 | |a Kim, Chang-Ho |e verfasserin |4 aut | |
700 | 1 | |a Park, Jae-Yong |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Respiration; international review of thoracic diseases |d 1968 |g (2024) vom: 18. März |w (DE-627)NLM000076384 |x 1423-0356 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:18 |g month:03 |
856 | 4 | 0 | |u http://dx.doi.org/10.1159/000538091 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 18 |c 03 |